gdc

Newsworthy

FDA Approvals, News & UpdatesLiver CancerNewsworthy
Previously approved for thyroid cancer and kidney cancer, the FDA has recently approved Lenvima as the first treatment for patients with liver cancer.
FDA Approvals, News & UpdatesKidney CancerNewsworthy
The use of Opdivo with Yervoy is the first immunotherapy combination therapy approved by the FDA for patients with kidney cancer.
Erleada First Drug Approved for Patients with Nonmetastatic Prostate Cancer
FDA Approvals, News & UpdatesNewsworthyProstate Cancer
On February 14, 2018, the FDA approved Erleada (apalutamide; from Janssen) for the treatment of patients with nonmetastatic, castration-resistant prostate cancer.
Verzenio Approved as Initial Treatment for Metastatic Breast Cancer
Breast CancerFDA Approvals, News & UpdatesNewsworthy
The CDK4/CDK6 inhibitor Verzenio received a new indication, for use alone or in combination with an aromatase inhibitor, as initial therapy in women with HR-positive, HER2-negative advanced or metastatic breast cancer.
Page 2 of 6
Results 11 - 20 of 59

Subscribe to CONQUER: the patient voice® magazine

Receive timely cancer news & updates, patient stories, and more.

Country